1. Nanoparticle-mediated therapeutic management in cholangiocarcinoma drug targeting: Current progress and future prospects
   Chunkang Liu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
2. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma
   Ghassan K. Abou-Alfa et al, 2022, Targeted Oncology CrossRef
3. Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma
   Sri Harsha Tella et al, 2023, The Oncologist CrossRef